Pfizer

News

Pfizer Healthcare Hub Challenge 2018 winners announced

A service that helps patients capture and share their experience and outcomes of care, in settings from trials to the clinic, is one of three 2018 Pfizer Healthcare Hub Challenge winners.

Market Access

NICE okays Roche rare lung cancer drug after price cut

Alecensa has aced Pfizer's rival in head-to-head trial

News

Mylan to market Lupin's Enbrel biosimilar outside US

Lupin's biosimilar is under review in EU

News

Pfizer expands venture arm with $600m cash boost

Pharma giant Pfizer is injecting $600 million into its venture investment arm in a bid to ramp up its involvement in biotechnology and other emerging growth companies.

Views & Analysis

Top pharmaceutical companies in the world in 2017

The rankings of the top pharmaceutical companies in the world in 2017 presented a mixed picture, with stability for some of the 25 largest firms as others saw their value fall.

News

NICE recommends Pfizer’s Xalkori in rare lung cancer

NICE has issued a Final Appraisal Determination that recommends the use of Pfizer’s Xalkori (crizotinib) in England under the Cancer Drugs Fund (CDF) for patients with ROS1-positive advanced non-small cell lung cancer (NSCLC).

Pfizer Healthcare Hub Challenge 2018 winners announced

NICE okays Roche rare lung cancer drug after price cut

Mylan to market Lupin's Enbrel biosimilar outside US

Pfizer expands venture arm with $600m cash boost

Top pharmaceutical companies in the world in 2017

NICE recommends Pfizer’s Xalkori in rare lung cancer

UK offers meningitis jab to young people after outbreak

Discover a new era of healthcare panel engagement: Grounded ...

Pfizer

Editor's Picks